Examkin

Soru

Zorluk: OrtaSubstance-Related and Addictive Disorders

A 26-year-old woman, G2P1, at 14 weeks gestation, comes to the clinic for an initial prenatal visit. She reports daily intravenous heroin use and states, "I want to stop using to protect my baby." Her last heroin use was 16 hours ago, and she currently exhibits yawning, rhinorrhea, and piloerection. Her medical history includes bipolar I disorder, but she stopped her mood stabilizer prior to conception. Over the past three weeks, she has experienced a pervasive low mood, anhedonia, and fatigue. She is adamant about not being admitted to the hospital, fearing she will be fired from her job if she misses work. Vital signs are within normal limits. Arterial blood gas analysis on room air shows:

- pH: 7.447.44
- PaCO 2_2: 30 mm Hg30\text{ mm Hg}
- PaO 2_2: 102 mm Hg102\text{ mm Hg}
- HCO 3−_3^-: 20 mEq/L20\text{ mEq/L}

Which of the following is the most appropriate next step in the management of this patient?

  1. A
    Obtain a court order for mandatory inpatient detoxification
  2. B
    Prescribe fluoxetine to manage the current depressive episode
  3. C
    Initiate carbon dioxide rebreathing therapy to correct the acid-base derangement
  4. Initiate outpatient buprenorphine therapyCevap
  5. E
    Disclose the patient's substance use disorder to her employer to mitigate workplace hazards

Cevap

The correct action is to initiate outpatient buprenorphine therapy.
The correct answer addresses the immediate need to stabilize the patient's opioid use disorder safely during pregnancy. The standard of care for pregnant patients with opioid use disorder is opioid agonist therapy (OAT) using either buprenorphine or methadone. Medically supervised withdrawal (detoxification) is generally contraindicated because it carries a high risk of relapse and can cause significant fetal distress or demise during periods of acute withdrawal. Since the patient has decision-making capacity and refuses inpatient admission, starting buprenorphine in the outpatient setting respects her autonomy while providing the safest evidence-based treatment for both her and the fetus.

Adım Adım Çözüm

1
Identify the primary clinical problem and patient's pregnancy status
The patient has active Opioid Use Disorder (OUD), is experiencing mild withdrawal, and is in the first trimester of pregnancy.
Pregnancy alters the standard management options for OUD due to severe fetal risks associated with acute opioid withdrawal.
2
Determine the standard of care for OUD during pregnancy
Opioid agonist therapy (OAT) with buprenorphine or methadone is indicated, while medically supervised withdrawal (detoxification) is avoided.
OAT prevents maternal withdrawal, reduces the risk of relapse to illicit opioids, and prevents withdrawal-induced fetal distress or demise.
3
Evaluate the ethical constraints and patient preferences regarding the setting of care
The patient refuses inpatient admission but retains decision-making capacity.
Competent pregnant patients cannot be forced into involuntary treatment solely for fetal benefit, making outpatient initiation of buprenorphine the safest, most ethical, and most appropriate next step.

Anahtar Kavram

The standard of care for opioid use disorder in pregnancy is opioid agonist therapy (buprenorphine or methadone). Medically supervised withdrawal is avoided due to the high risk of relapse and fetal distress. Furthermore, competent pregnant patients cannot be ethically forced into involuntary treatment against their will.
Bu soruyu puanla

Konular

Substance-Related and Addictive Disorders

Bu konudan daha fazla soru